Skip to main content
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1996 Mar;3(2):197–199. doi: 10.1128/cdli.3.2.197-199.1996

(1-->3) beta-D-glucan as a quantitative serological marker for Pneumocystis carinii pneumonia.

A Yasuoka 1, N Tachikawa 1, K Shimada 1, S Kimura 1, S Oka 1
PMCID: PMC170276  PMID: 8991635

Abstract

We detected (1 --> 3) beta-D-glucan (beta-glucan), which is one of the major components of the cyst wall of Pneumocystis carinii, in sera obtained from patients with P. carinii pneumonia (PCP). We confirmed that beta-glucan was detectable by a beta-glucan detection kit (G test; Seikagaku Corporation) in bronchoalveolar lavage fluids (BALFs). The mean concentration of beta-glucan in BALFs obtained from specific-pathogen-free nude mice infected with P. carinii (n = 7; mean, 2,631 [range, 1,031 to 9,095] pg/ml) was significantly higher (P < 0.001) than that in uninfected, specific-pathogen-free mice (n = 7; 6.5 [range, 4.0 to 8.3] pg/ml). The mean level of beta-glucan in BALFs from PCP patients was significantly higher (P < 0.05) than that in BALFs from patients with other lung diseases (7,268 [range, 1,355 to 15,500] pg/ml [n = 4] versus 242.5 [17 to 615] pg/ml [n = 4]). In sera from six of seven patients with PCP, significant levels of beta-glucan (494.1 [8.5 to 1,135] pg/ml) were detected, while it was undetectable in patients with other lung diseases and in a control group. In five patients at follow-up, the level of beta-glucan decreased with clinical improvement. These results suggest that beta-glucan is detectable in sera from patients with PCP and it is a practical serological marker for monitoring of the disease during treatment.

Full Text

The Full Text of this article is available as a PDF (180.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Edman J. C., Kovacs J. A., Masur H., Santi D. V., Elwood H. J., Sogin M. L. Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature. 1988 Aug 11;334(6182):519–522. doi: 10.1038/334519a0. [DOI] [PubMed] [Google Scholar]
  2. Hoffman O. A., Standing J. E., Limper A. H. Pneumocystis carinii stimulates tumor necrosis factor-alpha release from alveolar macrophages through a beta-glucan-mediated mechanism. J Immunol. 1993 May 1;150(9):3932–3940. [PubMed] [Google Scholar]
  3. Ikegami K., Ikemura K., Shimazu T., Shibuya M., Sugimoto H., Yoshioka T., Sugimoto T. Early diagnosis of invasive candidiasis and rapid evaluation of antifungal therapy by combined use of conventional chromogenic limulus test and a newly developed endotoxin specific assay. J Trauma. 1988 Aug;28(8):1118–1126. doi: 10.1097/00005373-198808000-00003. [DOI] [PubMed] [Google Scholar]
  4. Kitada K., Oka S., Kimura S., Shimada K., Serikawa T., Yamada J., Tsunoo H., Egawa K., Nakamura Y. Detection of Pneumocystis carinii sequences by polymerase chain reaction: animal models and clinical application to noninvasive specimens. J Clin Microbiol. 1991 Sep;29(9):1985–1990. doi: 10.1128/jcm.29.9.1985-1990.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kohno S., Mitsutake K., Maesaki S., Yasuoka A., Miyazaki T., Kaku M., Koga H., Hara K. An evaluation of serodiagnostic tests in patients with candidemia: beta-glucan, mannan, candida antigen by Cand-Tec and D-arabinitol. Microbiol Immunol. 1993;37(3):207–212. doi: 10.1111/j.1348-0421.1993.tb03201.x. [DOI] [PubMed] [Google Scholar]
  6. Kovacs J. A., Halpern J. L., Lundgren B., Swan J. C., Parrillo J. E., Masur H. Monoclonal antibodies to Pneumocystis carinii: identification of specific antigens and characterization of antigenic differences between rat and human isolates. J Infect Dis. 1989 Jan;159(1):60–70. doi: 10.1093/infdis/159.1.60. [DOI] [PubMed] [Google Scholar]
  7. Levin J., Poore T. E., Zauber N. P., Oser R. S. Detection of endotoxin in the blood of patients with sepsis due to gran-negative bacteria. N Engl J Med. 1970 Dec 10;283(24):1313–1316. doi: 10.1056/NEJM197012102832404. [DOI] [PubMed] [Google Scholar]
  8. Lipschik G. Y., Gill V. J., Lundgren J. D., Andrawis V. A., Nelson N. A., Nielsen J. O., Ognibene F. P., Kovacs J. A. Improved diagnosis of Pneumocystis carinii infection by polymerase chain reaction on induced sputum and blood. Lancet. 1992 Jul 25;340(8813):203–206. doi: 10.1016/0140-6736(92)90469-j. [DOI] [PubMed] [Google Scholar]
  9. Masur H. Prevention and treatment of pneumocystis pneumonia. N Engl J Med. 1992 Dec 24;327(26):1853–1860. doi: 10.1056/NEJM199212243272606. [DOI] [PubMed] [Google Scholar]
  10. Matsumoto Y., Matsuda S., Tegoshi T. Yeast glucan in the cyst wall of Pneumocystis carinii. J Protozool. 1989 Jan-Feb;36(1):21S–22S. doi: 10.1111/j.1550-7408.1989.tb02674.x. [DOI] [PubMed] [Google Scholar]
  11. Obayashi T., Yoshida M., Mori T., Goto H., Yasuoka A., Iwasaki H., Teshima H., Kohno S., Horiuchi A., Ito A. Plasma (1-->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet. 1995 Jan 7;345(8941):17–20. doi: 10.1016/s0140-6736(95)91152-9. [DOI] [PubMed] [Google Scholar]
  12. Oka S., Kitada K., Kohjin T., Nakamura Y., Kimura S., Shimada K. Direct monitoring as well as sensitive diagnosis of Pneumocystis carinii pneumonia by the polymerase chain reaction on sputum samples. Mol Cell Probes. 1993 Dec;7(6):419–424. doi: 10.1006/mcpr.1993.1062. [DOI] [PubMed] [Google Scholar]
  13. Schmatz D. M., Romancheck M. A., Pittarelli L. A., Schwartz R. E., Fromtling R. A., Nollstadt K. H., Vanmiddlesworth F. L., Wilson K. E., Turner M. J. Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors. Proc Natl Acad Sci U S A. 1990 Aug;87(15):5950–5954. doi: 10.1073/pnas.87.15.5950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Wakefield A. E., Guiver L., Miller R. F., Hopkin J. M. DNA amplification on induced sputum samples for diagnosis of Pneumocystis carinii pneumonia. Lancet. 1991 Jun 8;337(8754):1378–1379. doi: 10.1016/0140-6736(91)93062-e. [DOI] [PubMed] [Google Scholar]
  15. Yasuoka A., Oka S., Komuro K., Shimizu H., Kitada K., Nakamura Y., Shibahara S., Takeuchi T., Kondo S., Shimada K. Successful treatment of Pneumocystis carinii Pneumonia in mice with benanomicin A (ME1451). Antimicrob Agents Chemother. 1995 Mar;39(3):720–724. doi: 10.1128/AAC.39.3.720. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES